The added value Outcome Capital was responsible for was 10 times greater than the value we invested in their services. Our only regret was in not bringing them on sooner.
Outcome Capital has demonstrated an astute and insightful understanding of our value proposal and the major companies in the cardiovascular space. They provided us with invaluable strategic advice and I can’t think of better partners to have guided us through the process.
Advanced Uro-Solutions engaged the services of Outcome Capital late in the process of being acquired. Outcome Capital took control of all further negotiations and masterfully increased the value of our final offering. The added value Outcome Capital was responsible for was 10 times greater than the value we invested in their services. Our only regret was in not bringing them on sooner. Arnie and Oded brought an amazing team of talented, organized and highly effective individuals. We could NOT have been more satisfied.
Translating future value into current shareholder liquidity requires a balanced approach and diverse skill set. Especially for early-stage or pre-revenue life sciences companies, this problem is compounded. Our experienced scientific and financial teams combine to communicate your company’s unique value proposition and future market potential. With an array of transactional structures to select from, our team explores the various avenues available to facilitation value realization.
Our professionals are well-versed in structures ranging from outright M&A to build-to-buy option agreements, sales-based structured transactions to private-equity platform investments. Our deep network of senior executives spanning public, private, strategic and financial buyers facilitate quick and thoughtful market feedback instrumental towards crafting a market-aligned transaction strategy.
Would you like to learn more about working with Outcome Capital or discuss your specific needs?